Despite persistent disparities in HIV outcomes, communities disproportionately affected by the pandemic exhibit resilience across the treatment and prevention continua. Through his research, Dr. Meanley aims to leverage community stakeholder perspectives to translate identified resiliencies into effective HIV treatment and prevention programming.

Resources for HIV treatment and prevention continue to evolve beyond critical advances such as U=U and PrEP that have emerged over the past few years. Dr. Meanley’s program of research seeks to improve how HIV prevention experts and stakeholders understand the ways in which the roll out these advancements are maximized for priority populations across the intersections of adolescence, sexual and gender minority identity, and communities of color. This insight will not only be integral to facilitating individuals’ engagement across the HIV treatment and prevention continua, but will also inform service delivery initiatives as the next generation of treatment and prevention modalities become available.